Prostate cancer: Reducing fracture risk in men on androgen deprivation therapy.
Vahakn B
VB
Shahinian
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D050723:Fractures, Bone / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D017312:Toremifene / Q000627:therapeutic use*
D000726:Androgen Antagonists; D020845:Selective Estrogen Receptor Modulators; D017312:Toremifene